Companies
All companies
Pharmaceuticals, Biotechnology and Life Sciences
| Company | Jurisdiction | Industry | Near-term | Net Zero | Emissions (t CO2e) | Revenue (M USD) | Intensity (t CO₂e / M USD) | Year |
|---|---|---|---|---|---|---|---|---|
| AbbVie | Pharmaceuticals, Biotechnology and Life Sciences | Target set | Target set | 528,000 | 56,740 | 9 | 2022 | |
| Amgen Inc. | Pharmaceuticals, Biotechnology and Life Sciences | Target set | 3,469,000 | 25,930 | 134 | 2022 | ||
| AstraZeneca | Pharmaceuticals, Biotechnology and Life Sciences | Target set | Target set | 6,937,716 | 45,811 | 151 | 2023 | |
| Bayer AG | Pharmaceuticals, Biotechnology and Life Sciences | Target set | 13,110,000 | 53,330 | 246 | 2022 | ||
| BioGaia AB | Pharmaceuticals, Biotechnology and Life Sciences | Target set | 7,570 | 108 | 70 | 2022 | ||
| Bristol Myers Squibb | Pharmaceuticals, Biotechnology and Life Sciences | Committed | Committed | 2,060,297 | 45,850 | 45 | 2022 | |
| Danaher Corporation | Pharmaceuticals, Biotechnology and Life Sciences | Committed | 347,849 | 30,950 | 11 | 2022 | ||
| GSK | Pharmaceuticals, Biotechnology and Life Sciences | Target set | Target set | 645,000 | 37,725 | 17 | 2023 | |
| Gilead Sciences, Inc. | Pharmaceuticals, Biotechnology and Life Sciences | Target set | 111,338 | 27,370 | 4 | 2021 | ||
| Johnson & Johnson | Pharmaceuticals, Biotechnology and Life Sciences | Target set | 10,027,167 | 96,310 | 104 | 2022 | ||
| McKesson Corporation | Pharmaceuticals, Biotechnology and Life Sciences | Target set | 27,119,447 | 273,900 | 99 | 2022 | ||
| Novartis | Pharmaceuticals, Biotechnology and Life Sciences | Target set | Target set | 9,272,100 | 50,950 | 182 | 2022 | |
| Novo Nordisk A/S | Pharmaceuticals, Biotechnology and Life Sciences | Target set | 3,831,000 | 33,724 | 114 | 2023 | ||
| Orion Corporation | Pharmaceuticals, Biotechnology and Life Sciences | Target set | 431,404 | 1,288 | 335 | 2023 | ||
| Pfizer Inc. | Pharmaceuticals, Biotechnology and Life Sciences | Target set | 10,818,749 | 92,950 | 116 | 2022 | ||
| Recipharm | Pharmaceuticals, Biotechnology and Life Sciences | Target set | Target set | 1,828,439 | 1,293 | 1,414 | 2022 | |
| Red Glead Discovery AB | Pharmaceuticals, Biotechnology and Life Sciences | Target set | Target set | 842 | 6 | 140 | 2022 | |
| SANOFI | Pharmaceuticals, Biotechnology and Life Sciences | Target set | Target set | 5,007,437 | 45,190 | 111 | 2022 | |
| Takeda Pharmaceutical Company | Pharmaceuticals, Biotechnology and Life Sciences | Target set | Target set | 5,734,000 | 29,990 | 191 | 2022 | |
| Thermo Fisher Scientific Inc. | Pharmaceuticals, Biotechnology and Life Sciences | Target set | Target set | 13,337,413 | 43,810 | 304 | 2022 |